UCB Canada Inc. respectfully disagrees with the draft recommendation issued by the Canadian Drug Agency (CDA-AMC) regarding PrBIMZELX® (bimekizumab injection) for the treatment of adults living with ...
NMPA accepts Akeso’s supplemental New Drug Application for gumokimab to treat active ankylosing spondylitis: Hong Kong Wednesday, January 21, 2026, 12:00 Hrs [IST] Akeso Inc, a ...
Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing ...
Histologic tuberculosis eventually turned out to be necrotizing sarcoid granulomatosis, a rare disease. A retired TB ward nurse with recurrent uveitis, a positive TST, pulmonary masses and skeletal ...
Akeso is adding a pair of late-stage wins to its scorecard in both ankylosing spondylitis and atopic dermatitis while also teeing up a new drug submission for one of the candidates. The Hong ...
For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...
The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients globally living with spinal rigidity, morning stiffness and pain, bone ...
In this case, the patient does not have features fully consistent with a diagnosis of Crohn's disease. The presentation is more in keeping with a diagnosis of ileitis of spondylarthropathy. It can be ...
As we mark World Ankylosing Spondylitis Day on 03rd May 2025, it’s time to shine a spotlight on a frequently misunderstood cause of chronic back pain and help raise awareness among patients and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There were no new safety signals, while all fungal ...
Patients with ankylosing spondylitis with vs without comorbid inflammatory bowel disease had a lower prevalence of HLA-B27 positivity, enthesitis, and structural damage. Patients with ankylosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results